Αρχειοθήκη ιστολογίου

Σάββατο 26 Αυγούστου 2017

DEVELOPING DRUGS IN CANCER-RELATED BONE PAIN

S10408428.gif

Publication date: Available online 25 August 2017
Source:Critical Reviews in Oncology/Hematology
Author(s): Maurizio Lucchesi, Gaetano Lanzetta, Andrea Antonuzzo, Antonio Rozzi, Iacopo Sardi, Claudio Favre, Carla Ida Ripamonti, Daniele Santini, Grazia Armento
IntroductionCancer-related bone pain is a frequent and important key problem for metastatic patients that may reduce quality of life, with related limitations in daily activities and morbidity. Often traditional approach to pain may fail given the complex pathophysiology of this phenomenon.MethodsThe aim of this review is to describe promising therapies for cancer-related bone pain, from the pathophysiology to the clinical trials currently ongoing. Moreover, any new evidence for better approach to cancer-related bone pain with the traditional drugs is also considered.ConclusionsIn clinical practice opioids remain the most important pharmacologic treatment for severe pain related to bone cancer. Regard developing drugs, anti-NGF and anti-TrkA are the most investigated new drug in this setting, but a future role in clinical practice is still uncertain.



from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2xB2UAA

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου